217 related articles for article (PubMed ID: 6314173)
1. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.
Avellanosa AM; West CR; Tsukada Y; Higby DJ; Bakshi S; Reese PA; Jennings E
Cancer; 1979 Sep; 44(3):839-46. PubMed ID: 225004
[TBL] [Abstract][Full Text] [Related]
3. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.
Bremer AM; Kleriga E; Nguyen TQ; Balsys R; Northup HM; Gonzalez N; Duarte P; Miller RI
J Neurooncol; 1984; 2(2):129-32. PubMed ID: 6481425
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
5. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
6. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.
Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H
Neurosurgery; 1992 Feb; 30(2):223-7. PubMed ID: 1312230
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
Liau CT; Wei KC; Tseng CK; Jung SM
Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas.
Gundersen S; Lote K; Watne K
Eur J Cancer; 1998 Sep; 34(10):1565-9. PubMed ID: 9893629
[TBL] [Abstract][Full Text] [Related]
9. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y
Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
Afra D; Sipos L; Vitanovics D
Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
[TBL] [Abstract][Full Text] [Related]
12. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
13. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
Raizer JJ; Malkin MG; Kleber M; Abrey LE
Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine.
Prados M; Rodriguez L; Chamberlain M; Silver P; Levin V
Neurosurgery; 1989 Jun; 24(6):806-9. PubMed ID: 2546093
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors.
Comella G; Scoppa G; De Marco M; Ianniello GP; Melillo G; Coucourde F; Zarrilli D
J Neurooncol; 1985; 3(1):13-7. PubMed ID: 2987423
[TBL] [Abstract][Full Text] [Related]
16. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
17. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy.
Petronio J; Edwards MS; Prados M; Freyberger S; Rabbitt J; Silver P; Levin VA
J Neurosurg; 1991 May; 74(5):701-8. PubMed ID: 1901597
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
19. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
Safdari H; Mompeon B; Dubois JB; Gros C
Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]